EPRI (EndPoint Result Interpreter) is a next-generation AI-powered solution designed to simplify and accelerate the development of Health Technology Assessment (HTA) dossiers across Europe. Whether you're preparing submissions for Germany’s AMNOG, the UK’s NICE, or the EU’s Joint Clinical Assessment (JCA), EPRI delivers clarity, speed, and scientific rigour.
Case Study: Dossier to Go - Creating an AI Assisted AMNOG HTA Dossier in 3 Months
Supported by the use of EPRI—our innovative AI solution for tailored clinical data descriptions in HTA dossiers—a complete benefit dossier was successfully developed within just three months, a fraction of the usual timeframe. The efficiency gains in dossier preparation also enabled the preceding G-BA consultation to take place.
Read the latest EPRI Case Study
Find out more about EPRI on our >> Kintiga website.
Get in touch
Dr. rer. nat. Lydia Frick
Director Market Access
M.Sc. Psychology
Director Market Access
M.Sc. Psychology
Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18
Fax: +49 511 64 68 14 18
Kintiga unifies MAP Patient Access, AxTalis, and SKC with one name and one vision.
to the top